文献速递神经儿科影像MR

儿童患者齿状核与苍白球信号强度变化:脑照射及原发性脑肿瘤的影响,独立于线性钆基对比剂给药

Changes in Signal Intensity of the Dentate Nucleus and Globus Pallidus in Pediatric Patients: Impact of Brain Irradiation and Presence of Primary Brain Tumors Independent of Linear Gadolinium-based Contrast Agent Administration.
PubMed 文献 · Radiology · 2017-11-30

该研究纳入144例接受钆基对比剂增强MR检查的儿童患者,分为脑肿瘤伴全脑照射组、仅化疗组、未治疗组及无脑转移的神经母细胞瘤组;测量未增强T1WI上苍白球与丘脑、齿状核与脑桥的信号强度比值。结果显示,放疗组齿状核与脑桥比值高于其他组(除化疗组外),未治疗脑肿瘤组该比值随对比剂剂量增加而增高,且脑肿瘤组苍白球与丘脑比值高于神经母细胞瘤组,提示信号变化可独立于钆基对比剂给药而发生。

要点

  • 儿童脑肿瘤患者接受全脑照射或未治疗时,齿状核与苍白球信号强度变化可不依赖钆基对比剂给药。
  • 放疗组齿状核与脑桥信号比值高于其他组(除化疗组外),剂量≤10次时放疗组高于未治疗组,剂量>20次时未治疗组高于放疗组。
  • 脑肿瘤组苍白球与丘脑信号比值高于神经母细胞瘤组,提示原发脑肿瘤本身可能影响信号。

核心结论

  • 在儿童患者中,齿状核和苍白球信号强度的变化可独立于钆基对比剂给药而发生,见于接受脑照射的脑肿瘤患者以及未治疗的原发性脑肿瘤患者。

研究设计与样本

  • 经机构审查委员会批准、符合HIPAA的研究,纳入144例接受静脉钆基对比剂增强MR检查的儿童患者:55例原发性脑肿瘤伴全脑照射,19例原发脑肿瘤仅化疗,52例原发脑肿瘤未治疗,18例无脑转移的神经母细胞瘤;在未增强T1加权图像上测量苍白球、丘脑、齿状核和脑桥的信号强度,计算苍白球与丘脑、齿状核与脑桥信号强度比值,采用方差分析和多变量线性模型分析。

关键影像表现/征象

  • 齿状核与脑桥信号强度比值在放疗组高于其他组(除外仅化疗的脑肿瘤组),P < .05。
  • 苍白球与丘脑信号强度比值在脑肿瘤各组高于神经母细胞瘤组,P = .01。

诊断标准与关键数值

  • 齿状核与脑桥信号强度比值:放疗组高于其他组(除外仅化疗的脑肿瘤组),P < .05。
  • 齿状核与脑桥信号强度比值与钆基对比剂总累积剂量相关:未治疗脑肿瘤组P < .0001。
  • 齿状核与脑桥信号强度比值:剂量≤10次时,放疗组高于未治疗脑肿瘤组(P < .0001);剂量>20次时,未治疗脑肿瘤组高于放疗组(P = .05)。
  • 苍白球与丘脑信号强度比值:脑肿瘤各组高于神经母细胞瘤组,P = .01。

临床应用与阅片要点

  • 在儿童脑肿瘤患者的未增强T1WI上,齿状核和苍白球信号强度变化需结合放疗史、原发脑肿瘤本身及钆基对比剂累积剂量综合解读。
  • 对于未治疗的原发性脑肿瘤患儿,齿状核与脑桥信号强度比值可随钆基对比剂累积剂量增加而增高。
  • 放疗患儿的齿状核与脑桥信号强度比值在钆基对比剂剂量≤10次时高于未治疗脑肿瘤患儿,而剂量>20次时低于未治疗脑肿瘤患儿。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To determine whether whole-brain irradiation, chemotherapy, and primary brain pathologic conditions affect magnetic resonance (MR) imaging signal changes in pediatric patients independent of the administration of gadolinium-based contrast agents (GBCAs). Materials and Methods This institutional review board-approved, HIPAA-compliant study included 144 pediatric patients who underwent intravenous GBCA-enhanced MR imaging examinations (55 patients with primary brain tumors and whole-brain irradiation, 19 with primary brain tumors and chemotherapy only, 52 with primary brain tumors without any treatment, and 18 with neuroblastoma without brain metastatic disease). The signal intensities (SIs) in the globus pallidus (GP), thalamus (T), dentate nucleus (DN), and pons (P) were measured on unenhanced T1-weighted images. GP:T and DN:P SI ratios were compared between groups by using the analysis of variance and were analyzed relative to group, total cumulative number of doses of GBCA, age, and sex by using multivariable linear models. Results DN:P ratio for the radiation therapy group was greater than that for the other groups except for the group of brain tumors treated with chemotherapy (P < .05). The number of GBCA doses was correlated with the DN:P ratio for the nontreated brain tumor group (P < .0001). The radiation therapy-treated brain tumor group demonstrated higher DN:P ratios than the nontreated brain tumor group for number of doses less than or equal to 10 (P < .0001), whereas ratios in the nontreated brain tumor group were higher than those in the radiation therapy-treated brain tumor group for doses greater than 20 (P = .05). The GP:T ratios for the brain tumor groups were greater than that for the neuroblastoma group (P = .01). Conclusion Changes in SI of the DN and GP that are independent of the administration of GBCA occur in patients with brain tumors undergoing brain irradiation, as well as in patients with untreated primary brain tumors. © RSNA, 2017.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Tamrazi B, Nguyen B, Liu CJ, et al. Changes in Signal Intensity of the Dentate Nucleus and Globus Pallidus in Pediatric Patients: Impact of Brain Irradiation and Presence of Primary Brain Tumors Independent of Linear Gadolinium-based Contrast Agent Administration. Radiology. 2017. PMID: 29189102. doi:10.1148/radiol.2017171850

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。